Page last updated: 2024-09-05

nutlin 3 and Astrocytoma, Grade IV

nutlin 3 has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barresi, E; Cosconati, S; Da Pozzo, E; Da Settimo, F; Daniele, S; Di Maro, S; La Motta, C; La Pietra, V; Marinelli, L; Martini, C; Novellino, E; Robello, M; Taliani, S1

Other Studies

1 other study(ies) available for nutlin 3 and Astrocytoma, Grade IV

ArticleYear
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
    Journal of medicinal chemistry, 2016, 05-26, Volume: 59, Issue:10

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Models, Molecular; Molecular Structure; Proto-Oncogene Proteins c-mdm2; Receptors, GABA; Structure-Activity Relationship; Tumor Cells, Cultured

2016